C Klas

3.2k total citations · 2 hit papers
7 papers, 2.8k citations indexed

About

C Klas is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, C Klas has authored 7 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in C Klas's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers) and T-cell and B-cell Immunology (2 papers). C Klas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Immunotherapy and Immune Responses (2 papers) and T-cell and B-cell Immunology (2 papers). C Klas collaborates with scholars based in Germany, France and Netherlands. C Klas's co-authors include Klaus‐Michael Debatin, Werner Falk, Peter H. Krammer, Anke Peters, Peter Mӧller, S. Matzku, P H Krammer, Richard R. Jonker, Min Li‐Weber and Iris Behrmann and has published in prestigious journals such as Science, Journal of Biological Chemistry and Blood.

In The Last Decade

C Klas

7 papers receiving 2.7k citations

Hit Papers

Monoclonal Antibody-Mediated Tumor Regression by Inductio... 1989 2026 2001 2013 1989 1992 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Klas Germany 6 1.8k 1.5k 536 315 275 7 2.8k
Giovina Ruberti Italy 24 1.6k 0.9× 1.3k 0.9× 388 0.7× 274 0.9× 299 1.1× 61 3.0k
Peter Schow United States 17 2.1k 1.2× 1.4k 1.0× 760 1.4× 766 2.4× 297 1.1× 20 3.3k
Anan Chuntharapai United States 21 1.3k 0.7× 1.3k 0.9× 786 1.5× 380 1.2× 218 0.8× 30 2.4k
Asra Mirza United States 14 1.4k 0.8× 1.7k 1.1× 722 1.3× 197 0.6× 218 0.8× 16 3.0k
Michael J. Pinkoski United States 22 1.6k 0.9× 1.7k 1.1× 630 1.2× 317 1.0× 486 1.8× 38 3.1k
Nadir Mechti France 31 1.8k 1.0× 1.4k 0.9× 613 1.1× 286 0.9× 473 1.7× 61 3.3k
Frédérique Michel France 26 886 0.5× 2.2k 1.5× 657 1.2× 186 0.6× 256 0.9× 54 3.1k
Kathryn A. Hjerrild United States 12 1.8k 1.0× 2.0k 1.3× 653 1.2× 261 0.8× 175 0.6× 15 4.1k
D J Panka United States 12 972 0.5× 1.4k 0.9× 278 0.5× 233 0.7× 184 0.7× 18 2.0k
Michiyuki Maeda Japan 30 865 0.5× 2.4k 1.6× 566 1.1× 221 0.7× 130 0.5× 72 3.5k

Countries citing papers authored by C Klas

Since Specialization
Citations

This map shows the geographic impact of C Klas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Klas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Klas more than expected).

Fields of papers citing papers by C Klas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Klas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Klas. The network helps show where C Klas may publish in the future.

Co-authorship network of co-authors of C Klas

This figure shows the co-authorship network connecting the top 25 collaborators of C Klas. A scholar is included among the top collaborators of C Klas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Klas. C Klas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Dhein, Jens, Iris Behrmann, Peter T. Daniel, et al.. (1994). APO-I-mediated apoptosis in normal and malignant lymphocytes. Biochemical Society Transactions. 22(3). 598–600. 2 indexed citations
2.
Klas, C, Klaus‐Michael Debatin, Richard R. Jonker, & P H Krammer. (1993). Activation interferes with the APO-1 pathway in mature human T cells. International Immunology. 5(6). 625–630. 404 indexed citations
3.
Jonas, Daniel E, Beate Schultheis, C Klas, P H Krammer, & Sucharit Bhakdi. (1993). Cytocidal effects of Escherichia coli hemolysin on human T lymphocytes. Infection and Immunity. 61(5). 1715–1721. 57 indexed citations
4.
Behrmann, Iris, Werner Falk, Michael Pawlita, et al.. (1992). Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen.. Journal of Biological Chemistry. 267(15). 10709–10715. 746 indexed citations breakdown →
5.
Debatin, Klaus‐Michael, C Klas, A. B. Rickinson, et al.. (1992). Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood. 79(12). 3300–3306. 88 indexed citations
6.
Debatin, Klaus‐Michael, et al.. (1992). Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype. Blood. 79(12). 3300–3306. 11 indexed citations
7.
Klas, C, Anke Peters, S. Matzku, et al.. (1989). Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis. Science. 245(4915). 301–305. 1478 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026